Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Thread Formerly Known as No Rest For The Wicked -- Ignore unavailable to you. Want to Upgrade?

To: Jane4IceCream who wrote (68311)	10/27/1999 11:30:00 PM
From: microvestor	Read Replies (1) \| Respond to of 90042

Jane: If I may change the subject and talk about the long term prospects about a drug stock? I know that you follow the sector. ENMD (Entremed) is now going into phase III trials with their Endostatin cancer reducing drug. Kills tumors by cutting off their blood supply. (angiogenesis) They also are looking into the action of PSA as the body's natural defense against some kinds of cancer: quicken.com But, as so often is the case with biomeds, the stock as been a miserable performer. Any thoughts on this one... Are we looking at another potential IMCL tia Lee"microvestor"